Univariate and multivariable analysis for the association of cancer-related factors with IPE
Variable . | Univariate . | Multivariable . | ||
---|---|---|---|---|
OR (95% CI) . | P . | OR (95% CI) . | P . | |
Time from cancer diagnosis | ||||
>1 y | Reference | |||
≤1 y | 2.79 (2.37-3.29) | <.001 | 1.99 (1.66-2.38) | <.001 |
Cancer status | ||||
Stable | Reference | |||
Active | 6.17 (5.03-7.62) | <.001 | 4.50 (3.63-5.61) | <.001 |
Active cytotoxic chemotherapy | ||||
No | Reference | |||
Yes | 2.87 (2.42-3.40) | <.001 | 2.21 (1.84-2.66) | <.001 |
Active radiotherapy | ||||
No | Reference | |||
Yes | 5.41 (3.30-9.20) | <.001 | 4.28 (2.51-7.54) | <.001 |
Active hormonal therapy | ||||
No | Reference | |||
Yes | 0.56 (0.35-0.87) | .013 | 1.09 (0.66-1.76) | .726 |
Surgery within 30 d | ||||
No | Reference | |||
Yes | 3.13 (1.48-6.92) | .003 | 3.03 (1.33-7.19) | .009 |
Variable . | Univariate . | Multivariable . | ||
---|---|---|---|---|
OR (95% CI) . | P . | OR (95% CI) . | P . | |
Time from cancer diagnosis | ||||
>1 y | Reference | |||
≤1 y | 2.79 (2.37-3.29) | <.001 | 1.99 (1.66-2.38) | <.001 |
Cancer status | ||||
Stable | Reference | |||
Active | 6.17 (5.03-7.62) | <.001 | 4.50 (3.63-5.61) | <.001 |
Active cytotoxic chemotherapy | ||||
No | Reference | |||
Yes | 2.87 (2.42-3.40) | <.001 | 2.21 (1.84-2.66) | <.001 |
Active radiotherapy | ||||
No | Reference | |||
Yes | 5.41 (3.30-9.20) | <.001 | 4.28 (2.51-7.54) | <.001 |
Active hormonal therapy | ||||
No | Reference | |||
Yes | 0.56 (0.35-0.87) | .013 | 1.09 (0.66-1.76) | .726 |
Surgery within 30 d | ||||
No | Reference | |||
Yes | 3.13 (1.48-6.92) | .003 | 3.03 (1.33-7.19) | .009 |